Hot flash. Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
Conditions
Interventions
Intervention 1: In intervention group: Sedamin will be prescribed in the form of Oral Capsule 530 mg, Twice in a day along two months. This drug Will be bought from Goldaroo Company in Iran. Intervent
Treatment - Drugs
In intervention group: Sedamin will be prescribed in the form of Oral Capsule 530 mg, Twice in a day along two months. This drug Will be bought from Goldaroo Company in Iran.
In control group: placebo will be prescribed in the form of Oral Capsul contain 530 mg valeriana Twice in a day along two months.
Sponsors
Vice chancellor for research, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age of between 45-55; elapse of at least one and at most 5 years after menopausal; no using cigarette and alcohol; no having physical or mental diseases; no using of relaxation techniques; no using of hormonal or herbal therapies Exclusion criteria: drug intolerance; not complete treatment duration
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot flash severity. Timepoint: before the intervention, 1 month after intervention, 2 months after the intervention. Method of measurement: Cooperman Index.;Hot flash frequency. Timepoint: before the intervention, 1 month after intervention, 2 months after the intervention. Method of measurement: Cooperman Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Shobeiri
Hamadan University of Medical Sciences
Outcome results
None listed